###begin article-title 0
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Induction of Olig2+ Precursors by FGF Involves BMP Signalling Blockade at the Smad Level
###end article-title 0
###begin p 1
Conceived and designed the experiments: BB CFH AC NDA SC. Performed the experiments: BB CFH. Analyzed the data: BB CFH. Wrote the paper: BB CFH.
###end p 1
###begin p 2
###xml 579 587 579 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 592 599 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 688 696 688 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1086 1094 1086 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1630 1635 1630 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1952 1957 1952 1957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1028 1031 <span type="species:ncbi:10116">rat</span>
During normal development oligodendrocyte precursors (OPCs) are generated in the ventral spinal cord in response to Sonic hedgehog (Shh) signalling. There is also a second, late wave of oligodendrogenesis in the dorsal spinal cord independent of Shh activity. Two signalling pathways, controlled by bone morphogenetic protein and fibroblast growth factor (FGF), are active players in dorsal spinal cord specification. In particular, BMP signalling from the roof plate has a crucial role in setting up dorsal neural identity and its inhibition is sufficient to generate OPCs both in vitro and in vivo. In contrast, FGF signalling can induce OPC production from dorsal spinal cord cultures in vitro. In this study, we examined the cross-talk between mitogen-activated protein kinase (MAPK) and BMP signalling in embryonic dorsal spinal cord cultures at the SMAD1/5/8 (SMAD1) transcription factor level, the main effectors of BMP activity. We have previously shown that FGF2 treatment of neural precursor cells (NPCs) derived from rat E14 dorsal spinal cord is sufficient to generate OPCs in vitro. Utilising the same system, we now show that FGF prevents BMP-induced nuclear localisation of SMAD1-phosphorylated at the C-terminus (C-term-pSMAD1). This nuclear exclusion of C-term-pSMAD1 is dependent on MAPK activity and correlates with OLIG2 upregulation, the obligate transcription factor for oligodendrogenesis. Furthermore, inhibition of the MAPK pathway abolishes OLIG2 expression. We also show that SMAD4, which acts as a common partner for receptor-regulated Smads including SMAD1, associates with a Smad binding site in the Olig2 promoter and dissociates from it upon differentiation. Taken together, these results suggest that FGF can promote OPC generation from embryonic NPCs by counteracting BMP signalling at the Smad1 transcription factor level and that Smad-containing transcriptional complexes may be involved in direct regulation of the Olig2 promoter.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Gotz1">[1]</xref>
###xml 337 340 337 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Richardson1">[2]</xref>
###xml 738 741 738 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Pringle1">[3]</xref>
###xml 743 746 743 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Orentas1">[4]</xref>
###xml 881 884 881 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Loulier1">[5]</xref>
###xml 885 888 885 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Palma1">[8]</xref>
###xml 1152 1155 1152 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Vallstedt1">[9]</xref>
###xml 1157 1161 1157 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Cai1">[10]</xref>
###xml 1169 1177 1169 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1415 1419 1415 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kessaris1">[11]</xref>
###xml 1421 1425 1421 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Chandran1">[12]</xref>
###xml 1530 1534 1530 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Chandran1">[12]</xref>
###xml 1614 1622 1614 1622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo,</italic>
###xml 1525 1529 <span type="species:ncbi:10090">mice</span>
The vertebrate brain is composed of a variety of neural cell types which are generated from neural precursor cells (NPCs) that have the potential to differentiate into neurons, astrocytes, and oligodendrocytes [1]. Differentiation of NPCs into neurons and glia occurs in temporally distinct waves with neurogenesis preceding gliogenesis [2]. The origin of oligodendrocytes, the myelinating cells of the vertebrate central nervous system (CNS), has been studied extensively in the developing spinal cord and two distinct phases of oligodendrogenesis have been established. OPCs first originate from the motor neuron progenitor (pMN) domain of the ventral neural tube under the influence of Shh signalling from the notochord and floorplate [3], [4]. In addition Shh has been implicated in the proliferation, maintenance and migration of adult neural precursors and their derivatives [5]-[8]. The ventrally-derived OPCs migrate laterally and dorsally, populating the CNS before maturing into myelin-forming oligodendrocytes. A second phase of oligodendrogenesis takes place in the embryonic dorsal spinal cord (DSC) which is independent of Shh signalling [9], [10]. Using in vitro systems, it has been shown that Shh signalling is not essential for oligodendrogenesis as NPCs isolated from the embryonic spinal cord can generate oligodendrocytes in the presence of cyclopamine-KAAD (a potent blocker of hh signalling) [11], [12]. In addition, oligodendrocytes may still be produced by NPCs isolated from Shh functional knockout mice [12]. Later studies by Cai et al. (2005) and Vallstedt et al. (2005) confirmed that in vivo, oligodendrocytes originate in the developing DSC as well as in the ventral pMN domain.
###end p 4
###begin p 5
###xml 97 101 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-MunozSanjuan1">[13]</xref>
###xml 294 302 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 307 314 304 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 314 317 311 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Vallstedt1">[9]</xref>
###xml 319 323 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Miller1">[14]</xref>
###xml 325 329 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-MekkiDauriac1">[15]</xref>
###xml 429 433 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Attisano1">[16]</xref>
###xml 614 618 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague1">[17]</xref>
###xml 905 909 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague1">[17]</xref>
###xml 911 915 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague2">[18]</xref>
###xml 1093 1097 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague1">[17]</xref>
###xml 1401 1405 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague1">[17]</xref>
The BMPs are members of the TGF-beta family and are known inhibitors of neuronal differentiation [13]. In addition, BMP signalling is known to inhibit Shh-induced oligodendrogenesis and it has been shown that inhibition of BMP signalling is sufficient to induce oligodendrocyte generation both in vitro and in vivo[9], [14], [15]. BMPs are secreted signalling proteins that bind to cell-surface serine/threonine kinase receptors [16]. Activated receptor kinases in turn relay this signal to the nucleus via activation of Smad transcription factors, which is achieved by phosphorylation of the C-terminal SXS motif [17]. There are five mammalian receptor-regulated Smads (R-Smads) (Smads 1-3, 5 and 8) that serve as substrates for the TGF-beta receptor family. Smads 1, 5, and 8 are targets for BMP and anti-Mullerian receptors, whereas Smads 2 and 3 are regulated by TGF-beta, Nodal and activin receptors [17], [18]. In addition to receptor-mediated activation the formation of transcriptionally active Smad complexes also requires dimerisation of R-Smads with SMAD4, also referred as Co-Smad [17]. R-Smad/SMAD4 oligomers form the core of diverse multi-subunit transcriptional regulation complexes, which include other DNA sequence-specific binding proteins and co-factors. Altogether the combination of these factors determine target specificity, leading to activation or repression of certain genes [17].
###end p 5
###begin p 6
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Lu1">[19]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Woodruff1">[23]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Lu1">[19]</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Takebayashi1">[20]</xref>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig1</italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 599 607 599 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Chandran1">[12]</xref>
###xml 708 709 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 827 830 827 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Vallstedt1">[9]</xref>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Cai1">[10]</xref>
###xml 945 953 945 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 953 957 953 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kessaris1">[11]</xref>
###xml 959 963 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Chandran1">[12]</xref>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Cai1">[10]</xref>
###xml 1056 1057 1056 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1124 1127 1124 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Vallstedt1">[9]</xref>
Two bHLH transcription factors, Olig1 and Olig2, are also known to regulate oligodendrocyte specification in the developing nervous system [19]-[23]. Specifically, Olig2 is an obligate factor for oligodendrogenesis in the developing spinal cord as the disruption of Olig2 alone results in complete elimination of oligodendrocytes [19], [20]. Regulation of Olig1 and Olig2 expression presents a key step in oligodendrocyte differentiation and two signalling pathways, MAPK and BMP, are known to play opposing roles in this process. BMP mediated signalling blocks dorsal oligodendrocyte specification in vitro, and their generation is promoted when BMP signalling is inhibited [12]. Indeed, production of OLIG2+ dorsally-derived OPCs which arise later than their ventral counterparts correlates with a decrease in BMP signalling [9], [10]. In contrast, FGF signalling has been shown to promote Olig2 expression and oligodendrocyte differentiation in vitro[11], [12] via MAPK signalling, including in dorsal explants [10]. Furthermore, exposure of dorsal PAX7+ cells to a FGF receptor antagonist abolishes any OLIG2 expression [9] indicating that FGF activity is required for oligodendrogenesis in the DSC.
###end p 6
###begin p 7
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague1">[17]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague2">[18]</xref>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Pera1">[24]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kretzschmar1">[25]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Sapkota1">[26]</xref>
BMP-regulated Smads lie at the crossroads of the antagonistic signalling interplay between MAPK and BMP pathways. BMP receptor kinases relay signals through C-terminal phosphorylation and nuclear translocation of the transcription factor SMAD1, whereas MAPKs catalyse inhibitory phosphorylation in the SMAD1 linker region that results in the cytoplasmic sequestration of SMAD1 [17], [18], [24], [25]. Recently, the regulation of SMAD1 activity has been elucidated in detail revealing interplay of MAPK, Smurf1 and nucleoporin interactions that control the cytoplasmic sequestration and turnover of SMAD1 protein [26].
###end p 7
###begin p 8
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Here, we show that BMP signalling pathway is active in rat embryonic DSC precursor cultures and that the MAPK pathway is responsive to FGF2 treatment. We also show that BMP-activated SMAD1, that is C-term-pSMAD1, is sequestered in the cytoplasm in a MAPK-dependent manner accompanied with increased OLIG2 expression suggesting that FGF2 can potentially antagonise BMP signalling in the embryonic DSC during oligodendrogenesis. SMAD4, which is also referred as Co-Smad due to its dimerisation with R-Smads, associates with the Olig2 promoter in undifferentiated cells and this interaction is lost upon induction of Olig2 transcription suggesting that BMP signalling may directly regulate Olig2 expression.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Smad expression and MAPK signalling activity in DSC precursor cultures
###end title 10
###begin p 11
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Cai1">[10]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kessaris1">[11]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Tsang1">[27]</xref>
###xml 931 935 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Chandran1">[12]</xref>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Warf1">[28]</xref>
We and others have shown that FGF2 can induce Shh-independent production of oligodendrocytes by dissociated NPCs and in dorsal explants [10], [11]. FGFs, through binding to their cognate receptors, activate several signal transduction cascades including the extracellular signal-regulated protein kinase (ERK) cascade which is part of the canonical MAPK pathway [27]. MAPK pathway activators counterbalance BMP action during neurogenesis, bone formation, and other aspects of vertebrate development. BMP receptors signal through C-terminal phosphorylation and nuclear translocation of the transcription factor SMAD1, whereas MAPK catalyses inhibitory phosphorylation in the SMAD1 linker region. To determine if such a mechanism of action is responsible for FGF2 dependent oligodendrogenesis from rodent dorsal cord, we established primary cultures of DSC NPCs from E14 embryos, at which point there are no constitutive dorsal OPCs [12], [28].
###end p 11
###begin p 12
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad 1</italic>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad1</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad5</italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad8</italic>
###xml 288 297 288 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g001">Figure 1A</xref>
###xml 335 340 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 342 351 342 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad1/5/8</italic>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad1</italic>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad5</italic>
###xml 524 527 <span type="species:ncbi:10116">rat</span>
First, we established the expression pattern of the downstream effectors of BMP signalling in our culture system. Semi-quantitative RT-PCR expression analysis of Smad 1, 5, and 8 revealed that Smad1 and Smad5 were expressed at high levels whereas Smad8 transcript levels were much lower (Figure 1A, compare cycle numbers 26 and 30 for Gapdh, Smad1/5/8). All three transcripts were readily detected in total E14 trunk cDNA at cycle 30. These results showed that there is preferential expression of Smad1 and Smad5 in the E14 rat dorsal spinal cord.
###end p 12
###begin title 13
Smad expression, MAPK signalling analysis and quantification of OLIG2 expressing cells in DSC neural precursor cell cultures.
###end title 13
###begin p 14
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad1</italic>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 54 55 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</italic>
###xml 82 85 <span type="species:ncbi:10116">rat</span>
###xml 115 118 <span type="species:ncbi:10116">Rat</span>
A. Semi-quantitative RT-PCR analysis of Smad1, 5, and 8 expression in primary E14 rat dorsal spinal cord cultures. Rat E14 trunk cDNA was used as positive control. B. Western blot analysis of extracts from different DSC culture conditions using anti-phospho ERK1/2 polyclonal antibody to assess MAPK activity. Anti-ERK2 antibody was used as a loading control. C. Primary cultures of E14 dorsal neural precursor cells were treated with FGF2, BMP4 or FGF2+U0126 for 6, 24 or 72 hours and stained for OLIG2 expression. Pictographs showing representative fields for different culture conditions after 72 hours of treatment. D. Cells expressing OLIG2 were counted and represented as percent of the total cell number. Data represent mean +/- SEM. FGF2 treatment 72 h time point is statistically different from 6 and 24 h (ANOVA with Tukey HSD test, p<0.01). FGF2 treatment is also statistically different at each time point compared to other conditions (*,p<0.05; **, p<0.0001; *** p<0.0001; ANOVA with Tukey HSD).
###end p 14
###begin p 15
###xml 529 538 529 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g001">Figure 1B</xref>
###xml 753 762 753 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g001">Figure 1B</xref>
We next examined the MAPK pathway activity in different DSC culture conditions. Primary DSC precursor cells were cultured for 12 hours after isolation and were subsequently treated for 6 hours with FGF2, FGF2+U0126 (an inhibitor of MAPK signalling), BMP4 or DMSO (control). Western blotting using an antibody to phospho-ERK1/2, specific for the active form of the enzyme, enabling assessment of MAPK activity, was next undertaken. A low level of MAPK activity in DSC cells was detected under control and BMP4-treated conditions (Figure 1B). Treatment of DSC precursor cultures with FGF2, however, resulted in robust activation of MAPK signalling pathway as judged by increased levels of phospho-ERK1/2. This effect was reduced in the presence of U0126 (Figure 1B). These results are consistent with the absence of strong, sustained MAPK activity in dissociated DSC cultures and further that MAPK signal transduction pathway is responsive to stimulation by FGF2 treatment.
###end p 15
###begin title 16
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
FGF2 induces OLIG2+ cells
###end title 16
###begin p 17
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 60 76 60 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g001">Figure 1C and 1D</xref>
###xml 267 268 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 276 289 274 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g001">Fig 1C and 1D</xref>
###xml 375 376 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 517 530 511 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g001">Fig 1C and 1D</xref>
###xml 623 624 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 702 711 696 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g001">Figure 1D</xref>
###xml 905 906 899 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Following confirmation of very low numbers of OLIG2+ cells (Figure 1C and 1D, control 6h 0.45+/-0.12%) in primary DSC cultures, we next examined whether FGF2 treatment results in upregulation of OLIG2 expression. Addition of BMP4 did not significantly influence OLIG2+ cells (Fig 1C and 1D). However, treatment with FGF2 resulted in a substantial increase in numbers of OLIG2+ cells; 1.46+/-0.26% and 6.25+/-1.00% after 24 and 72 hours, respectively and was significant compared to control and BMP4 treated cultures (Fig 1C and 1D). Co-treatment with MAPK inhibitor U0126 and FGF2 resulted in a negligible increase in OLIG2+ cells indicating FGF2-induced OLIG2 expression is MAPK signalling dependent (Figure 1D). To investigate whether increased BMP signalling can antagonise induction of OLIG2 expression by FGF2, primary DSC cultures were co-treated with FGF2 and BMP4 for 72 hours. The number of OLIG2+ cells was reduced by 60.75% compared to FGF2 only (p<0.01) suggesting that BMP signalling can directly compete with the effects of FGF2.
###end p 17
###begin title 18
FGF2 regulates sub-cellular localisation of SMAD1
###end title 18
###begin p 19
###xml 367 376 367 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g001">Figure 1B</xref>
###xml 581 590 581 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g002">Figure 2A</xref>
###xml 661 670 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g002">Figure 2A</xref>
###xml 1007 1023 1007 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g002">Figure 2A and 2B</xref>
Receptor-mediated phosphorylation of Smad factors at the C-terminus (C-term-pSmad) results in their nuclear accumulation, ultimately converting the BMP signal to a transcriptional readout. To analyse the subcellular localisation of C-term-pSMAD1 in response to different growth conditions, dissociated cells were grown in the presence or absence of FGF2 (as shown in Figure 1B) for different periods of time and the localisation of C-term-pSMAD1 examined using immunocytochemistry. Under control conditions, when BMP signalling was active, C-term-pSMAD1 was predominantly nuclear (Figure 2A). Addition of BMP4 resulted in a near exclusive nuclear localisation (Figure 2A). FGF2 treatment for 6 hours resulted in nuclear exclusion of C-term-pSMAD1. To test if the effect of FGF2 on C-term-pSMAD1 localisation was due to MAPK activity, the specific MEK inhibitor U0126 was added to DSC cultures. Addition of U0126 together with FGF2 abolished the cytoplasmic sequestration/nuclear exclusion of C-term-pSMAD1 (Figure 2A and 2B) showing that C-term-pSMAD1 requires MAPK signalling for its nucleo-cytoplasmic shuttling.
###end p 19
###begin title 20
FGF2 regulates sub-cellular localisation of SMAD1.
###end title 20
###begin p 21
###xml 694 699 <span type="species:ncbi:9606">human</span>
###xml 710 713 <span type="species:ncbi:10116">rat</span>
A. Primary cultures of E14 dorsal neural precursor cells were treated with FGF2, BMP4 or FGF2+U0126 for 6 hours or 24 hours and labelled for C-term-pSMAD1. Representative fields from 6 hours treatment is shown. B. Cells showing an exclusive nuclear or an exclusive cytoplasmic localisation were counted and are represented as a percent of total C-term-pSMAD1 expressing cells. Data represent mean +/- SEM. FGF2 treatment at each time point is statistically different from the three other groups (ANOVA and t-Test with Bonferonni, p<0.001). C. Alignment of the linker regions of receptor-regulated Smads and identification of MAPK phosphorylation sites. Conserved phosphorylation motifs between human SMAD1 and rat SMADs are highlighted in grey; green marking the peptide L-pSMAD1 antibody is raised against. D. Primary cultures of E14 dorsal neural precursor cells were treated with FGF2, or BMP4 for 6 hours and stained for L-pSMAD1. Representative fields are shown. E. Comparison of L-pSMAD1 cytoplasmic/nuclear signal levels between FGF2 and BMP4 treated samples. Data represent mean +/- SEM (p<0.05, paired T-test).
###end p 21
###begin p 22
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Pera1">[24]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kretzschmar1">[25]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kretzschmar1">[25]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Sapkota1">[26]</xref>
###xml 662 671 662 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g002">Figure 2C</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kuroda1">[29]</xref>
###xml 926 935 926 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g002">Figure 2C</xref>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kuroda1">[29]</xref>
###xml 1305 1314 1305 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g002">Figure 2D</xref>
###xml 1457 1466 1457 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g002">Figure 2D</xref>
###xml 1643 1652 1643 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g002">Figure 2E</xref>
###xml 2157 2161 2157 2161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Miller1">[14]</xref>
###xml 2163 2167 2163 2167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-MekkiDauriac1">[15]</xref>
###xml 323 329 <span type="species:ncbi:9606">humans</span>
###xml 739 744 <span type="species:ncbi:9606">human</span>
###xml 755 758 <span type="species:ncbi:10116">rat</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
###xml 903 906 <span type="species:ncbi:10116">rat</span>
###xml 1150 1153 <span type="species:ncbi:10116">rat</span>
###xml 1940 1943 <span type="species:ncbi:10116">rat</span>
###xml 2329 2332 <span type="species:ncbi:10116">rat</span>
It has previously been shown that deactivation of SMAD1 requires phosphorylation at the linker region by the MAPK pathway [24], [25] and that this linker phosphorylation event can result in cytoplasmic retention of SMAD1 [25]. There are four MAPK phosphorylation sites conserved between linker regions of Smad1, 5 and 8 in humans [26]. To investigate if there was a change in linker-phosphorylated SMAD1 (L-pSMAD1) levels in response to FGF2 treatment, we repeated the earlier experiment with analysis of L-pSMAD1 expression. The polyclonal antibody used to detect L-pSMAD1 was raised against the fourth MAPK phosphorylation site in the linker region of hSMAD1 (Figure 2C) [29]. Amino acid sequence alignment between the linker regions of human SMAD1 and rat SMAD1, 5 and 8 proteins showed that the fourth MAPK phosphorylation site, and the antigen used for immunisation, is identical between human and rat Smad1 orthologues (Figure 2C, [29]). Sequence alignment also revealed that the fourth phosphorylation site was conserved in Smad5 but was not present in Smad8 suggesting that L-pSMAD1 antibody is likely to recognise both linker-phosphorylated rat Smad1 and Smad5 paralogues. Upon FGF2 treatment, cytoplasmic L-pSMAD1 levels increased and was clearly visible in cytoplasmic processes of some cells (Figure 2D, compare control and FGF2 treated). Furthermore, BMP4 treatment did not effect the basal level of L-pSMAD1 as detected by immunofluorescence (Figure 2D) and the quantification of cytoplasmic/nuclear L-pSMAD1 signal ratios showed that FGF2 treatment resulted in 73% increase in L-pSMAD1 levels in the cytoplasm compared to BMP4 (Figure 2E, relative cytoplasmic/nuclear signal intensity: FGF2 1.335 +/- 0.156, BMP4 0.71 +/- 0.23, p<0.05, paired T-test). Taken together, these data suggest that FGF2 treatment can antagonise BMP signalling by regulating the subcellular localisation of SMAD1 via the MAPK pathway in dissociated rat embryonic DSC cultures and that OLIG2 expression correlates with nuclear exclusion of C-term-pSMAD1. Since Shh and FGF2 signaling provide independent mechanisms of inducing Olig2 expression and oligodendrogenesis [14], [15] one possibility would be for activated-SMAD subcellular localisation to provide a point of cross-talk between the two pathways. However, analysis of Shh treated rat DSC cells did not result in any significant subcellular localisation change of C-term-pSMAD1 (result not shown) suggesting that SMAD signalling does not provide a point of cross-talk between the two pathways.
###end p 22
###begin title 23
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
SMAD4 associates with Smad binding sites in Olig2 promoter
###end title 23
###begin p 24
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Lu1">[19]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Zhou1">[30]</xref>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Zhou2">[31]</xref>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Xian1">[32]</xref>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Ying1">[33]</xref>
###xml 810 815 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 920 925 920 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 969 978 969 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g003">Figure 3A</xref>
###xml 1173 1182 1173 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g003">Figure 3A</xref>
###xml 1184 1188 1184 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Wichterle1">[34]</xref>
###xml 1190 1194 1190 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Bouhon1">[35]</xref>
###xml 1313 1318 1313 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1350 1354 1350 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Quandt1">[36]</xref>
###xml 1356 1360 1356 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Loots1">[37]</xref>
###xml 1445 1452 1445 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1611 1615 1611 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague1">[17]</xref>
###xml 1733 1742 1733 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g003">Figure 3B</xref>
###xml 1853 1858 1853 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1871 1880 1871 1880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g003">Figure 3A</xref>
###xml 1956 1965 1956 1965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g003">Figure 3B</xref>
###xml 2036 2041 2036 2041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
###xml 1307 1312 <span type="species:ncbi:10090">mouse</span>
###xml 1401 1406 <span type="species:ncbi:10090">mouse</span>
###xml 1411 1414 <span type="species:ncbi:10116">rat</span>
Olig2 is a bHLH transcription factor with a critical role in both motor neuron and oligodendrocyte specification. Its expression is regulated both temporally and spatially during neural development [19], [30], [31] . However, the promoter of the Olig2 gene is not described in the literature and there is limited information on trans-acting factors that regulate its expression. Recently, using mouse embryonic stem (mES) cells as a model for analysing neural gene transcription it was shown that Olig2 has a complex promoter structure with a 2 kb proximal region that contributes significantly to promoter activity [32]. In mES cells BMP4 acts in combination with LIF to sustain self-renewal and preserve multilineage differentiation potential [33]. To investigate if BMP4 signalling can potentially regulate Olig2 expression via Smads undifferentiated mES cells were studied. Undifferentiated mES cells do not express Olig2 as determined by semi-quantitative RT-PCR (Figure 3A) but can be induced, in defined conditions, upon addition of FGF2 or with combinatorial application of FGF2, retinoic acid and Shh during directed differentiation of mES cells to motor neurons (Figure 3A) [34], [35]. Putative Smad binding sites were determined in the 4 kb upstream sequence from the transcription start site of mouse Olig2 using MatInspector and rVista2 [36], [37]. Four sites which are conserved between mouse and rat were chosen to be studied for in vivo SMAD4 association using chromatin immunoprecipitation. SMAD4 was chosen on the basis that all Smad transcriptional complexes identified to date contain SMAD4 [17]. Our results indicate that Smad4 binds specifically to one of these promoter elements in undifferentiated mES cells (Figure 3B, BS3). Interestingly, upon directed differentiation of mES cells towards motor neurons, with concomitant high Olig2 expression (Figure 3A, d8 F/R/S lane), SMAD4 occupancy at BS3 is no longer detectable with ChIP (Figure 3B) suggesting that SMAD4 containing complexes may directly regulate the Olig2 promoter.
###end p 24
###begin title 25
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
SMAD4, co-partner for all Receptor-Smads, binds to Olig2 promoter.
###end title 25
###begin p 26
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 833 838 833 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1035 1040 1035 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
A. Semi-quantitative RT-PCR analysis of Olig2 expression in undifferentiated (control) and neuralised (FGF2 only and FGF2/Shh/Retinoic Acid (F/S/R)) W9.5 mES cells. mES cells neuralised in chemically defined medium (CDM) for 4 days were further differentiated for 4 days in CDM+FGF2 (d8 FGF) or CDM+F/S/R (d8 F/S/R). Olig2 transcription is not detected in undifferentiated mES cells but is strongly induced upon 4 day differentiation in FGF2/Shh/Retinoic Acid containing medium. B. Schematic representation of putative Smad binding sites (BS) targeted for analysis in 4 kb promoter region of Olig2. PCR products identified by agarose gel electrophoresis after chromatin immunoprecipitation from W9.5 mES cells with Smad4 antibody. Smad4 binding was detected at BS3 only. No Smad4 binding is detected using beads only or at 3' UTR of Olig2. Smad4 binding at BS3 site is lost upon differentiation. Nucleotides represented in uppercase are exact matches to previously described consensus binding sequences at respective Smad sites in the Olig2 promoter. The positions of the binding sites are shown relative to the transcription start site.
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
Fate specification and differentiation requires the interplay of multiple developmental signals. We provide evidence using a well characterised developmental model that dorsal cord induction of Olig2 is dependent on MAPK activity that antagonises BMP mediated signalling resulting in cytoplasmic sequestering of C-term-pSMAD1. Furthermore, we provide evidence that SMAD4, a common partner for receptor-regulated Smads including SMAD1, associates with a Smad binding site in the Olig2 promoter with subsequent dissociation upon differentiation.
###end p 28
###begin p 29
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kuroda1">[29]</xref>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad1</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad5</italic>
###xml 705 712 705 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 740 744 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kuroda1">[29]</xref>
###xml 106 113 <span type="species:ncbi:8355">Xenopus</span>
###xml 365 368 <span type="species:ncbi:10116">rat</span>
###xml 705 712 <span type="species:ncbi:8355">Xenopus</span>
In general, it is believed that BMP signalling prevents neuronal differentiation. However, in dissociated Xenopus embryonic ectodermal cells sustained MAPK activity causes neuronal differentiation despite the presence of BMP signalling, showing that MAPK signalling can counteract the BMP pathway [29]. Our results show that BMP signalling is intact in dissociated rat embryonic DSC cultures, where the transcription factors Smad1 and Smad5 are transcribed highly and BMP receptor kinase-activated SMAD1, C-term-pSMAD1, is present. However, there is no strong and sustained MAPK activity in embryonic DSC cultures, demonstrated by very low levels of activated ERK1/2 in control conditions, in contrast to Xenopus embryonic ectodermal cells [29]. Nevertheless, treatment with FGF2 resulted in activation of the MAPK pathway revealing that DSC derived NPCs are responsive to MAPK activators. Further experiments are needed to determine which FGF receptors are present on precursor cells.
###end p 29
###begin p 30
###xml 239 242 239 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Vallstedt1">[9]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Cai1">[10]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kessaris2">[38]</xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Cai1">[10]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Chandran1">[12]</xref>
###xml 650 653 650 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Vallstedt1">[9]</xref>
###xml 655 659 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Cai1">[10]</xref>
###xml 743 750 743 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 1026 1030 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Pera1">[24]</xref>
###xml 1031 1035 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Sapkota1">[26]</xref>
###xml 1099 1103 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Sapkota1">[26]</xref>
###xml 1148 1152 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Sapkota1">[26]</xref>
###xml 1154 1158 1154 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kretzschmar2">[39]</xref>
###xml 1385 1389 1385 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Sapkota1">[26]</xref>
###xml 1854 1858 1854 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague1">[17]</xref>
###xml 676 681 <span type="species:ncbi:10090">mouse</span>
###xml 743 750 <span type="species:ncbi:8355">Xenopus</span>
Developmental origin of oligodendrocytes has been an area of much study. In addition to early restricted ventral foci of OPCs, recent studies have determined a second dorsal wave of oligodendrogenesis both in the spinal cord and forebrain [9], [10], [38]. The early ventral phase of spinal cord oligodendrogenesis originates in the pMN domain. The second dorsal derived wave, in contrast to oligodendrocyte generation in the ventral neural tube, is independent of Shh-signalling [10]-[12]. It is suggested that oligodendrogenesis in the developing dorsal neural tube results from integration of FGF signalling and decreasing BMP action in the region [9], [10]. Recent work on mouse mesencyhmal progenitor cells and neuroectodermal explants in Xenopus has elucidated, at the molecular level, how MAPK signalling can oppose BMP activity via the SMAD1 transcription factor. Signalling events triggered by different factors such as FGF8, IGF2, JNK and p38 can all lead to linker-phosphorylation of SMAD1 via MAPK pathway activity [24]-[26]. This in turn leads to degradation of SMAD1 via the proteasome [26] and/or cytoplasmic retention of the protein [26], [39]. The nuclear exclusion and degradation of SMAD1 are not mutually exclusive events as the binding of SMURF1 to SMAD1, which leads to SMAD1 polyubiquitination also inhibits the interaction of SMAD1 with the nuclear pore complex [26]. Our results suggest that FGF signalling can directly counteract BMP action in DSC precursor cells by regulating the subcellular localisation of BMP receptor-kinase activated SMAD1 (C-term-pSMAD1). The transcriptionally active form of SMAD1, C-term-pSMAD1, is predominantly nuclear under control conditions where there is ongoing BMP signalling. Receptor-regulated Smads undergo continuous nucleo-cytoplasmic shuttling enabling them to respond to changing stimuli [17]. We report that treatment of DSC precursor cultures with FGF2 activates the MAPK pathway and results in rapid cytoplasmic sequestration of C-term-pSMAD1, thereby inhibiting BMP signalling. Concomitantly, linker-phosphorylated SMAD1 (L-pSMAD1) levels were observed to increase in the cytoplasm. Furthermore, the basal level of cytoplasmic L-pSMAD1 signal observed in cells under BMP and control conditions suggest a continuous turn-over of the Smad1 protein in DSC neural precursor cells.
###end p 30
###begin p 31
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Lu1">[19]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-TekkiKessaris1">[21]</xref>
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Zhou1">[30]</xref>
###xml 216 217 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 582 590 582 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 618 625 618 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Spagnoli1">[40]</xref>
###xml 656 660 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Keller1">[43]</xref>
###xml 895 897 895 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id</italic>
###xml 978 982 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Ying1">[33]</xref>
###xml 1064 1069 1064 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1138 1143 1138 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1248 1253 1248 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1334 1339 1334 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1396 1401 1396 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad4</italic>
###xml 1541 1546 1541 1546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1558 1562 1558 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Colak1">[44]</xref>
###xml 1808 1812 1808 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Massague1">[17]</xref>
###xml 1945 1949 1945 1949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Murtaugh1">[45]</xref>
###xml 2105 2109 2105 2109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kim1">[46]</xref>
###xml 2221 2226 2221 2226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 2459 2464 2459 2464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad1</italic>
###xml 2469 2474 2469 2474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad5</italic>
###xml 2641 2646 2641 2646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Olig2</italic>
###xml 1415 1420 <span type="species:ncbi:10090">mouse</span>
Oligodendrogenesis in the CNS is regulated by two bHLH transcription factors, Olig1 and Olig2 [19]-[21], [30]. Treatment of DSC precursor cells with FGF2 resulted in significant and rapid increase in numbers of OLIG2+ cells that correlated with the de-activation/cytoplasmic sequestration of SMAD1. One outstanding question is whether the Olig2 promoter is regulated by Smads directly. Recent developments of detailed differentiation protocols for neural cells from mES cells provide a valuable platform to study the regulation of neural gene transcription. ES cell differentiation in vitro is thought to recapitulate in vivo developmental programmes [40]-[43]. In mES cells BMP4 acts in combination with LIF to sustain self-renewal and preserve multilineage differentiation, chimera colonisation, and germline transmission properties. A critical contribution of BMP4 is to induce expression of Id genes via the Smad pathway, which suppresses differentiation to neural lineages [33]. Our ChIP results show that SMAD4, also known as Co-Smad, can associate with the Olig2 promoter in undifferentiated mES cells. Moreover, upon induction of Olig2 expression in mES cells during motor neuron differentiation SMAD4 is displaced from the BS3 site on the Olig2 promoter suggesting that BMP signalling may directly regulate the expression of Olig2. Recently it was shown that the conditional deletion of Smad4 in the adult mouse subependymal zone resulted in elevated expression of OLIG2, implicating SMAD4 containing complexes in the modulation of Olig2 expression [44]. Upon activation by phosphorylation, receptor-regulated Smads (Smad1/5/8 in the case of BMP signalling) dimerise with SMAD4 and assemble multi-protein transcription regulatory complexes that target several promoters for activation or repression [17]. For instance, the transcriptional repressor Nkx3.2, which can induce chondrocyte differentiation in the presence of BMP signalling [45], forms a complex with SMAD1/SMAD4 and mSin3/HDAC co-repressor complex demonstrating that BMP-activated Smads can be involved in transcriptional repression [46]. It is thus plausible that BMP signalling assembles a SMAD-dependent transcriptional repression complex on the Olig2 promoter and that FGF2 signalling via MAPK activity relieves this repression by sequestering SMAD1 in the cytoplasm. The presence of multiple highly homologous receptor-regulated Smads in tissues, as in the high level expression of Smad1 and Smad5 in DSC precursor cells, raises the possibility of functional redundancy among the transcription factor family. Further functional studies are required to investigate Olig2 promoter structure, contribution of the putative Smad binding sites to the promoter activity along with the associated Smads and the composition of the transcriptional regulation complexes that may target these sites.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33
Primary and mES cell culture
###end title 33
###begin p 34
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Chandran1">[12]</xref>
###xml 849 850 837 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1300 1301 1284 1285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 144 147 <span type="species:ncbi:10116">rat</span>
###xml 284 288 <span type="species:ncbi:10116">rats</span>
The care and treatment of the animals used in this study was in accordance with UK Home Office and University of Cambridge regulations. Primary rat DSC cultures were performed as previously described [12]. Briefly, spinal cords were dissected out from embryonic day 14 Sprague Dawley rats (Charles River Laboratories, U.K.). Only the dorsal columns were collected. The tissue was dissociated in 0.1% trypsin (Sigma, U.K.) for 15 min at 37degreesC and after addition of DNase (0.001%, Sigma, U.K.) and centrifugation at 1,000 g for 3 min, cells were platted on poly-d-lysine coverslips at 50,000 cells/well in 6 wells plates and grown in Dulbecco's Modified Eagle's Medium (DMEM, Gibco, Invitrogen, U.K.) containing 2% B27 supplements (Gibco. Invitrogen, U.K.) and 1% penicillin/streptomycin and amphotericin (PSF, Sigma, U.K.) at 37degreesC in 5% CO2. When tested, growth factors were added after an overnight culture at the following concentrations: FGF2 20 ng/ml (R&D Systems Inc.), BMP4 10 ng/ml (R&D Systems Inc.) and U0126 10 microM. Cells were grown for 6 to 72 h before analysis. W9.5 mES cell line was maintained and neuralised as explained in detail in Bouhon et al., (2006). Briefly, enzymatically dissociated mES cells were resuspended in chemically defined medium (CDM) and plated at 1x105 cells per ml in 10-cm bacteriological grade culture dishes. Cultures were passaged by dissociating spheres by mechanical trituration. At day 4, cultures were treated with either FGF2 (control) or FGF2/Shh/Retinoic acid (neuralisation) for 4 more days. Growth factors were used at the following concentrations: fibroblast growth factor 2 (FGF2), 20 ng/ml (R&D Systems Inc.); Sonic hedgehog N-terminal peptide (SHH-N), 250 ng/ml (R&D Systems Inc.); all-trans-retinoic acid (RA), 1 microM (Sigma-Aldrich).
###end p 34
###begin title 35
Immunocytochemistry
###end title 35
###begin p 36
###xml 1443 1447 1431 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Kuroda1">[29]</xref>
###xml 262 266 <span type="species:ncbi:9925">goat</span>
###xml 436 439 <span type="species:ncbi:9685">Cat</span>
###xml 598 602 <span type="species:ncbi:9925">goat</span>
###xml 608 614 <span type="species:ncbi:9986">rabbit</span>
###xml 1161 1165 <span type="species:ncbi:9925">goat</span>
###xml 1171 1177 <span type="species:ncbi:9986">rabbit</span>
After 6, 24, or 72 h in culture, cells were washed with PBS and fixed 5 min with 4% paraformaldehyde. For C-term-pSMAD1 staining, cells were washed 3 times with PBS and permeabilized with ice-cold methanol for 10 min at -20degreesC. After blocking in 10% normal goat serum (NGS) in PBS containing 0.05% Triton X100 for 1 h, cells were incubated overnight at 4degreesC with anti-pSMAD1/5/8 antibody (Cell Signaling Technologies, U.S.A., Cat no: 9511S, phosphoSmad1/5/8 (Ser 463/465, Ser 426/428, Ser 463/465)) diluted 1:100 in PBS containing 2% NGS and 0.05% Triton X100. After three washes in PBS, goat anti-rabbit antibody coupled to biotin (Molecular Probes, Invitrogen ,1:200 in PBS) was applied for 1 h at room temperature then FITC-coupled streptavidin (Molecular Probes, Invitrogen ,1:200 in PBS) and Hoescht (Sigma, 1:5000 in PBS) were applied for 1 hour at room temperature. For Olig2 staining, cells were washed 3 times with PBS, blocked in PBS/10% NGS/0.05% Triton X100 for 1 h, and incubated overnight at room temperature with anti-Olig2 antibody (gift from Dr. Takeyabashi) diluted 1:3,000 in 2%NGS/PBS/0.05% Triton X100. After three washes in PBS, goat anti-rabbit coupled to Alexa 488 (Molecular Probes, Invitrogen, 1:500 in PBS) was applied for 1 h at room temperature together with Hoescht (Sigma, 1:5000). L-pSMAD1 polyclonal antibody was kindly provided by Dr. De Robertis and was used at 1:5000 following standard protocols [29]. Coverslips were mounted in Vectashield mounting medium (Vectra Laboratories, U.K.)
###end p 36
###begin title 37
Quantification and statistical analysis
###end title 37
###begin p 38
Immunofluorescence was observed under a Leitz microscope at high magnification (x40) and at least 5 fields/coverslips, 2 coverslips/experiment from at least 3 different experiments (n = 5 for Olig2 quantification) were taken into pictures for quantification. For Olig2 staining, the number of positive cells as well as the total number of cells were counted. C-term-pSMAD1 staining was counted in the different cellular compartments and total cell number was assessed. The mean value of the 2 coverslips of each experiment was used to calculate the average and the standard error between the different experiments. The significance of the different treatments on C-term-pSMAD1 localisation and on Olig2 expression were assessed by one-way analysis of variance (ANOVA) followed by Tukey HSD test or t-Test with Bonferoni correction, as indicated in the text. Cytoplasmic/nuclear L-pSMAD1 levels were quantified using ImageJ software with MRI Cell Image Analyzer plugin, averaged over 4 random fields/experiment from 4 different experiments.
###end p 38
###begin title 39
Immunoblotting
###end title 39
###begin p 40
###xml 351 362 <span type="species:ncbi:3704">horseradish</span>
###xml 438 444 <span type="species:ncbi:9986">rabbit</span>
Immunoblotting was carried out according to standard procedures. Protein samples were subjected to electrophoresis on denaturing 10% polyacrylamide gels, which were then transferred to PVDL membranes (Immobilon-P, Millipore) and analyzed by Western blotting. The proteins were detected with ECL reagent (GE Healthcare) in conjunction with appropriate horseradish peroxidase coupled secondary antibodies (BioRad). The antibodies used were rabbit polyclonal anti-ERK2 (Santa-Cruz SC-154) and anti-phospho p44/42 MAPK (Thr 202/Tyr204) (Cell Signaling Technologies 9101S).
###end p 40
###begin title 41
RNA Isolation and RT-PCR
###end title 41
###begin p 42
###xml 46 49 <span type="species:ncbi:10116">rat</span>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
Total cellular RNA was extracted from primary rat DSC cultures or undifferentiated or neuralised W9.5 mES cells using the RNeasy Mini isolation kit (Qiagen). RNase-free-DNase (New England Biolabs) treated RNA samples (2 microg) were reverse transcribed in 100 microl with random hexamers using MMLV RT (Invitrogen) according to manufacturer's protocol. PCR was conducted in 25 microl reaction volume using 2 microl cDNA synthesised as described above with BioTaq polymerase (BioLine). The primers used were: mouse hypoxanthine phosphoribosyl-transferase (mHPRT) forward:
###end p 42
###begin p 43
###xml 0 30 0 30 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCTACTGTAATGATCAGTCAACG-3&#8242;</named-content>
5'-AGCTACTGTAATGATCAGTCAACG-3';
###end p 43
###begin p 44
###xml 15 42 15 42 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AGAGGTCCTTTTCACCAGCA-3&#8242;</named-content>
mHPRT reverse: 5'- AGAGGTCCTTTTCACCAGCA-3';
###end p 44
###begin p 45
###xml 16 42 16 42 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTGGCTTCAAGTCATCTTCC-3&#8242;</named-content>
mOlig2 forward: 5'-GTGGCTTCAAGTCATCTTCC-3';
###end p 45
###begin p 46
###xml 16 42 16 42 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTAGATCTCGCTCACCAGTC-3&#8242;</named-content>
mOlig2 reverse: 5'-GTAGATCTCGCTCACCAGTC-3';
###end p 46
###begin p 47
###xml 19 47 19 47 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGCCAGCCGCTATGAATGTGA-3&#8242;</named-content>
###xml 0 3 <span type="species:ncbi:10116">rat</span>
rat Smad1 forward: 5'- GGCCAGCCGCTATGAATGTGA-3';
###end p 47
###begin p 48
###xml 16 43 16 43 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGGAACTCGCAGCATTCCAG-3&#8242;</named-content>
rSmad1 reverse: 5'-TGGGAACTCGCAGCATTCCAG-3';
###end p 48
###begin p 49
###xml 16 44 16 44 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGCTCTGACGATTCGTATCAA-3&#8242;</named-content>
rSmad5 forward: 5'- GGCTCTGACGATTCGTATCAA-3';
###end p 49
###begin p 50
###xml 16 44 16 44 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AGGAAACTCACAAATATCCAA-3&#8242;</named-content>
rSmad5 reverse: 5'- AGGAAACTCACAAATATCCAA-3';
###end p 50
###begin p 51
###xml 16 44 16 44 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TCCGAGTCAGACAGTCCTTAT-3&#8242;</named-content>
rSmad8 forward: 5'- TCCGAGTCAGACAGTCCTTAT-3';
###end p 51
###begin p 52
###xml 16 44 16 44 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GTACAAATGCACACCCTTTCC-3&#8242;</named-content>
rSmad8 reverse: 5'- GTACAAATGCACACCCTTTCC-3';
###end p 52
###begin p 53
###xml 16 41 16 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCCAGTATGACTCTACCC-3&#8242;</named-content>
rGAPDH forward: 5'-TTCCAGTATGACTCTACCC-3';
###end p 53
###begin p 54
###xml 16 43 16 43 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGGACTGTGGTCATGAGCCC-3&#8242;</named-content>
rGAPDH reverse: 5'-ATGGACTGTGGTCATGAGCCC-3'. To compensate for variable RNA and cDNA yields, the expression of HPRT was used as a control in mES experiments for which the optimal number of PCR cycles for linear amplification was determined. The amplification products were analyzed by agarose gel electrophoresis.
###end p 54
###begin title 55
Chromatin Immunoprecipitation
###end title 55
###begin p 56
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Quandt1">[36]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002863-Loots1">[37]</xref>
###xml 310 319 310 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002863-g003">Figure 3B</xref>
Chromatin immunoprecipitation was carried out with polyclonal Smad4 antibody (Santa Cruz Biotechnology, SC-7154X) using a modified protocol (PROT11) which can be found at . Smad binding sites were identified using MatInspector and rVista2 [36], [37]. Primers were designed to encompass the selected sites (see Figure 3B for details) as follows:
###end p 56
###begin p 57
###xml 13 39 13 39 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAGTCCTTGCACAATTGCGT-3&#8242;</named-content>
BS2 forward: 5'-TAGTCCTTGCACAATTGCGT-3';
###end p 57
###begin p 58
###xml 12 41 12 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGCCAGAAGGACTGTAGAATGG-3&#8242;</named-content>
BS2 reverse 5'-AAGCCAGAAGGACTGTAGAATGG-3';
###end p 58
###begin p 59
###xml 13 42 13 42 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCTATCTCCCGCATATTGTACC-3&#8242;</named-content>
BS3 forward: 5'-ACCTATCTCCCGCATATTGTACC-3';
###end p 59
###begin p 60
###xml 13 41 13 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GACCCATAACCGTTCAATTAGC-3&#8242;</named-content>
BS3 reverse: 5'-GACCCATAACCGTTCAATTAGC-3';
###end p 60
###begin p 61
###xml 13 42 13 42 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATAAATATCCCAACAAACAAACA-3&#8242;</named-content>
BS4 forward: 5'-ATAAATATCCCAACAAACAAACA-3';
###end p 61
###begin p 62
###xml 13 44 13 44 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATTCCTAGGTTTTCACTTCCATAA-3&#8242;</named-content>
BS4 reverse: 5'-AATTCCTAGGTTTTCACTTCCATAA-3';
###end p 62
###begin p 63
###xml 13 40 13 40 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTCCTCCCATCCCTCCTCGC-3&#8242;</named-content>
BS5 forward: 5'-CCTCCTCCCATCCCTCCTCGC-3';
###end p 63
###begin p 64
###xml 13 41 13 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGTTCCGCTGGTTTTTATAGC-3&#8242;</named-content>
BS5 reverse: 5'- GGTTCCGCTGGTTTTTATAGC-3';
###end p 64
###begin p 65
###xml 21 49 21 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- ATTGGTTTCTTACCCGACTGG-3&#8242;</named-content>
Olig2 3'UTR forward: 5'- ATTGGTTTCTTACCCGACTGG-3';
###end p 65
###begin p 66
###xml 22 49 22 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGTCACGTGAACAAAGAGC-3&#8242;</named-content>
Olig2 3' UTR reverse: 5'-GGAGTCACGTGAACAAAGAGC-3'.
###end p 66
###begin p 67
The authors thank Dr De Robertis for the generous donation of the linker- phospho-Smad antibody. We would also like to thank Natalie Bull and Sharon Prince for critical reading of the manuscript.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
The cell biology of neurogenesis.
###end article-title 69
###begin article-title 70
Oligodendrocyte wars.
###end article-title 70
###begin article-title 71
Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains.
###end article-title 71
###begin article-title 72
Sonic hedgehog signaling is required during the appearance of spinal cord oligodendrocyte precursors.
###end article-title 72
###begin article-title 73
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Increase of proliferating oligodendroglial progenitors in the adult mouse brain upon Sonic hedgehog delivery in the lateral ventricle.
###end article-title 73
###begin article-title 74
###xml 148 152 <span type="species:ncbi:10116">rats</span>
Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion.
###end article-title 74
###begin article-title 75
Sonic hedgehog promotes the migration and proliferation of optic nerve oligodendrocyte precursors.
###end article-title 75
###begin article-title 76
Sonic hedgehog controls stem cell behavior in the postnatal and adult brain.
###end article-title 76
###begin article-title 77
Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain.
###end article-title 77
###begin article-title 78
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling.
###end article-title 78
###begin article-title 79
Cooperation between sonic hedgehog and fibroblast growth factor/MAPK signalling pathways in neocortical precursors.
###end article-title 79
###begin article-title 80
FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway.
###end article-title 80
###begin article-title 81
Neural induction, the default model and embryonic stem cells.
###end article-title 81
###begin article-title 82
Patterning of spinal cord oligodendrocyte development by dorsally derived BMP4.
###end article-title 82
###begin article-title 83
###xml 94 99 <span type="species:ncbi:9031">chick</span>
Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord.
###end article-title 83
###begin article-title 84
The Smads.
###end article-title 84
###begin article-title 85
Smad transcription factors.
###end article-title 85
###begin article-title 86
The logic of TGFbeta signaling.
###end article-title 86
###begin article-title 87
Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system.
###end article-title 87
###begin article-title 88
Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3.
###end article-title 88
###begin article-title 89
Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon.
###end article-title 89
###begin article-title 90
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 75 82 <span type="species:ncbi:8355">Xenopus</span>
A human condensin complex containing hCAP-C-hCAP-E and CNAP1, a homolog of Xenopus XCAP-D2, colocalizes with phosphorylated histone H3 during the early stage of mitotic chromosome condensation.
###end article-title 90
###begin article-title 91
Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives.
###end article-title 91
###begin article-title 92
Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction.
###end article-title 92
###begin article-title 93
Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1.
###end article-title 93
###begin article-title 94
Balancing BMP signaling through integrated inputs into the Smad1 linker.
###end article-title 94
###begin article-title 95
Promotion and attenuation of FGF signaling through the Ras-MAPK pathway.
###end article-title 95
###begin article-title 96
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Evidence for the ventral origin of oligodendrocyte precursors in the rat spinal cord.
###end article-title 96
###begin article-title 97
###xml 55 62 <span type="species:ncbi:8355">Xenopus</span>
Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation.
###end article-title 97
###begin article-title 98
Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors.
###end article-title 98
###begin article-title 99
The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2.
###end article-title 99
###begin article-title 100
Promoter analysis in ES cell-derived neural cells.
###end article-title 100
###begin article-title 101
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3.
###end article-title 101
###begin article-title 102
Directed differentiation of embryonic stem cells into motor neurons.
###end article-title 102
###begin article-title 103
Embryonic stem cell-derived neural progenitors display temporal restriction to neural patterning.
###end article-title 103
###begin article-title 104
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.
###end article-title 104
###begin article-title 105
rVISTA 2.0: evolutionary analysis of transcription factor binding sites.
###end article-title 105
###begin article-title 106
Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage.
###end article-title 106
###begin article-title 107
The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.
###end article-title 107
###begin article-title 108
Guiding embryonic stem cells towards differentiation: lessons from molecular embryology.
###end article-title 108
###begin article-title 109
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Lineage choice and differentiation in mouse embryos and embryonic stem cells.
###end article-title 109
###begin article-title 110
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Neural differentiation of mouse embryonic stem cells.
###end article-title 110
###begin article-title 111
Embryonic stem cell differentiation: emergence of a new era in biology and medicine.
###end article-title 111
###begin article-title 112
Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells.
###end article-title 112
###begin article-title 113
###xml 4 9 <span type="species:ncbi:9031">chick</span>
The chick transcriptional repressor Nkx3.2 acts downstream of Shh to promote BMP-dependent axial chondrogenesis.
###end article-title 113
###begin article-title 114
Smad-dependent recruitment of a histone deacetylase/Sin3A complex modulates the bone morphogenetic protein-dependent transcriptional repressor activity of Nkx3.2.
###end article-title 114
###begin p 115
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 115
###begin p 116
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was funded by the Husky Foundation, Medical Research Council (UK), BBSRC and Sir David Walker. Funding bodies had no input on design and conduct of experiments or interpretation of data.
###end p 116

